# Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
Canonical URL: https://biopharmsignal.com/news/AMRX/amneal-pharmaceuticals-added-to-sandp-smallcap-600r-index
Ticker: AMRX
Company: Amneal Pharmaceuticals
Source: Amneal Pharmaceuticals
Published: 2026-01-28 21:05 EST
Original Source URL: https://investors.amneal.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-17 12:00 EST — [Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations](https://biopharmsignal.com/news/AMRX/amneal-expands-iohexol-injection-portfolio-with-u-s-fda-approval-of-additional-s-5f3ad56b) — Source: Amneal Pharmaceuticals
- 2026-07-09 20:05 EST — [Amneal to Report Second Quarter 2026 Results on July 30, 2026](https://biopharmsignal.com/news/AMRX/amneal-to-report-second-quarter-2026-results-on-july-30-2026-e7677e7f) — Source: Amneal Pharmaceuticals
- 2026-07-08 20:30 EST — [Amneal and Adalvo Announce FDA Acceptance for Review of Two U.S. ANDAs for Generic Tirzepatide Autoinjector](https://biopharmsignal.com/news/AMRX/amneal-and-adalvo-announce-fda-acceptance-for-review-of-two-u-s-andas-for-generi-0a6b37df) — Source: Amneal Pharmaceuticals
- 2026-07-01 12:30 EST — [Amneal’s New U.S. Sterile Manufacturing Facility Selected for FDA PreCheck Pilot Program](https://biopharmsignal.com/news/AMRX/amneal-s-new-u-s-sterile-manufacturing-facility-selected-for-fda-precheck-pilot--2719d102) — Source: Amneal Pharmaceuticals
- 2026-06-29 07:00 EST — [Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations](https://biopharmsignal.com/news/AMRX/zambon-and-amneal-announce-positive-chmp-opinion-for-hopledo-ipx203-for-adults-w-6b0e1405) — Source: Amneal Pharmaceuticals
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)